We are live on ! Find out more
SSIA

Spero-Smith Investment Advisers Portfolio holdings

AUM $74.5M
1-Year Est. Return 12.27%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+12.27%
3 Year Est. Return
+31.25%
5 Year Est. Return
10 Year Est. Return
AUM
$80.2M
AUM Growth
+$451K
Cap. Flow
-$700K
Cap. Flow %
-0.87%
Top 10 Hldgs %
43.54%
Holding
49
New
1
Increased
18
Reduced
18
Closed

Top Buys

Rank Stock Value
1
WOR icon
Worthington Enterprises
WOR
+$196K
2
CVS icon
CVS Health
CVS
+$21.9K
3
TGT icon
Target
TGT
+$20.1K
4
WFC icon
Wells Fargo
WFC
+$13.4K
5
CERN
Cerner Corp
CERN
+$10K

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$637K
2
XOM icon
ExxonMobil
XOM
+$55.4K
3
UNH icon
UnitedHealth
UNH
+$53.3K
4
VZ icon
Verizon
VZ
+$43.4K
5
CVX icon
Chevron
CVX
+$42.8K

Sector Composition

Rank Sector Weight
1 Technology 19.22%
2 Energy 19.14%
3 Healthcare 17.37%
4 Financials 10.82%
5 Communication Services 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$653B
$13M 16.22%
138,855
-627
-0.4% -$55.4K
SHW icon
2
Sherwin-Williams
SHW
$85.1B
$2.96M 3.7%
30,291
DHR icon
3
Danaher
DHR
$140B
$2.83M 3.53%
41,714
-298
-0.7% -$19.5K
FISV
4
Fiserv Inc
FISV
$29.7B
$2.52M 3.14%
46,282
-70
-0.2% -$3.6K
WFC icon
5
Wells Fargo
WFC
$258B
$2.4M 3%
50,780
+275
+0.5% +$13.4K
CVS icon
6
CVS Health
CVS
$137B
$2.33M 2.91%
24,384
+220
+0.9% +$21.9K
VZ icon
7
Verizon
VZ
$201B
$2.28M 2.84%
40,866
-836
-2% -$43.4K
ACN icon
8
Accenture
ACN
$106B
$2.24M 2.79%
19,749
-5,495
-22% -$637K
TRV icon
9
Travelers Companies
TRV
$82.3B
$2.19M 2.73%
18,401
+5
+0% +$566
INTC icon
10
Intel
INTC
$419B
$2.16M 2.69%
65,798
+39
+0.1% +$1.22K
TMO icon
11
Thermo Fisher Scientific
TMO
$213B
$2.13M 2.65%
14,412
-80
-0.6% -$11.8K
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.09T
$2.07M 2.58%
58,840
-500
-0.8% -$18K
MSFT icon
13
Microsoft
MSFT
$2.94T
$2.07M 2.58%
40,380
-330
-0.8% -$17.1K
HBAN icon
14
Huntington Bancshares
HBAN
$34.3B
$1.91M 2.38%
213,151
+430
+0.2% +$4.23K
ANSS
15
DELISTED
Ansys
ANSS
$1.9M 2.37%
20,986
-40
-0.2% -$3.54K
MCK icon
16
McKesson
MCK
$105B
$1.84M 2.3%
9,885
-95
-1% -$16.7K
SNI
17
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$1.83M 2.28%
29,332
+85
+0.3% +$5.43K
CELG
18
DELISTED
Celgene Corp
CELG
$1.81M 2.26%
18,375
+20
+0.1% +$2.07K
NVS icon
19
Novartis
NVS
$300B
$1.79M 2.23%
24,253
+140
+0.6% +$9.67K
EMC
20
DELISTED
EMC CORPORATION
EMC
$1.79M 2.23%
65,902
-625
-0.9% -$16.9K
SRCL
21
DELISTED
Stericycle Inc
SRCL
$1.76M 2.19%
16,883
+50
+0.3% +$5.35K
CERN
22
DELISTED
Cerner Corp
CERN
$1.69M 2.1%
28,765
+180
+0.6% +$10K
PEG icon
23
Public Service Enterprise Group
PEG
$39B
$1.56M 1.95%
33,482
-410
-1% -$18.6K
PG icon
24
Procter & Gamble
PG
$339B
$1.45M 1.81%
17,114
-281
-2% -$23.1K
ECL icon
25
Ecolab
ECL
$78.8B
$1.41M 1.76%
11,895
-110
-0.9% -$12.8K

Similar funds

Spero-Smith Investment Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, Spero-Smith Investment Advisers held 49 positions worth $80.2M, up 0.57% from $79.8M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 2%. Spero-Smith Investment Advisers opened 1 new position and made no exits, leaving the 49-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Energy and Healthcare.

  • Spero-Smith Investment Advisers's largest Q2 2016 buy was Worthington Enterprises: 8,470 shares worth $221K.
  • Spero-Smith Investment Advisers added most to CVS Health in Q2 2016, an estimated $21.9K increase.
  • Spero-Smith Investment Advisers's biggest Q2 2016 reduction was Accenture, cutting an estimated $637K.
  • Spero-Smith Investment Advisers's ten largest holdings make up 44% of its $80.2M portfolio in Q2 2016.
  • Spero-Smith Investment Advisers opened 1 new position and closed 0 in Q2 2016.
  • Spero-Smith Investment Advisers's portfolio value rose 0.57% quarter-over-quarter to $80.2M.

Based on Spero-Smith Investment Advisers's 13F filing for Q2 2016, filed 3 Aug 2016.